AmerisourceBergen Corporation (ABG) - Total Assets
Based on the latest financial reports, AmerisourceBergen Corporation (ABG) holds total assets worth €78.36 Billion EUR as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
AmerisourceBergen Corporation - Total Assets Trend (2019–2025)
This chart illustrates how AmerisourceBergen Corporation's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
AmerisourceBergen Corporation - Asset Composition Analysis
Current Asset Composition (September 2025)
AmerisourceBergen Corporation's total assets of €78.36 Billion consist of 68.2% current assets and 31.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.7% |
| Accounts Receivable | €25.23 Billion | 32.9% |
| Inventory | €20.49 Billion | 26.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €3.77 Billion | 4.9% |
| Goodwill | €13.68 Billion | 17.9% |
Asset Composition Trend (2019–2025)
This chart illustrates how AmerisourceBergen Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AmerisourceBergen Corporation's current assets represent 68.2% of total assets in 2025, a decrease from 71.8% in 2019.
- Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, down from 8.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 22.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 32.9% of total assets.
AmerisourceBergen Corporation Competitors by Total Assets
Key competitors of AmerisourceBergen Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.49 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
China | HK$50.56 Billion |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
AmerisourceBergen Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.92 | 0.92 | 0.92 |
| Quick Ratio | 0.51 | 0.54 | 0.55 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-4.98 Billion | €-4.52 Billion | €-3.41 Billion |
AmerisourceBergen Corporation - Advanced Valuation Insights
This section examines the relationship between AmerisourceBergen Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 36.51 |
| Latest Market Cap to Assets Ratio | 0.77 |
| Asset Growth Rate (YoY) | 14.1% |
| Total Assets | €76.59 Billion |
| Market Capitalization | $59.07 Billion USD |
Valuation Analysis
Below Book Valuation: The market values AmerisourceBergen Corporation's assets below their book value (0.77x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: AmerisourceBergen Corporation's assets grew by 14.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AmerisourceBergen Corporation (2019–2025)
The table below shows the annual total assets of AmerisourceBergen Corporation from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | €76.59 Billion | +14.14% |
| 2024-09-30 | €67.10 Billion | +7.26% |
| 2023-09-30 | €62.56 Billion | +10.60% |
| 2022-09-30 | €56.56 Billion | -1.36% |
| 2021-09-30 | €57.34 Billion | +30.47% |
| 2020-09-30 | €43.95 Billion | +12.19% |
| 2019-09-30 | €39.17 Billion | -- |
About AmerisourceBergen Corporation
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical cli… Read more